
National Express Group Plc
National Express Group Plc (LON: NEX) is a Birmingham, United Kingdom-based transport service provider, which operates in the UK, North Africa, the Middle East, Continental Europe, and North America.
The Company will announce full-year results on 25 February 2021.
Investment Highlights - National Express Group Plc – Sell at GBX 224.60
Key Risks
Trading Update (released on 24 September 2020)
One Year Share Price Chart

(Source: Refinitiv, chart created by Kalkine Group)
Valuation Methodology: Price/Cash Flow Approach (NTM) (Illustrative)

Conclusion
The Company witnessed an improvement in the trading environment and traded slightly above previous guided base case, while uncertainty remained. Due to imposed travel restriction and enforcement of social distancing protocols, the operational and financial performance impacted for the short-term period. NEX demonstrated tight cost control to generate positive EBITDA and cash flow and won new contracts. With the increased number of covid-19 cases, the growth projects might delay or put on hold. The stock made a 52-week low and high of GBX 66.30 and GBX 485.00, respectively.
Based on the risks associated and support from valuation done using the above method, we have given a “Sell” recommendation for National Express Group Plc at the current price of GBX 224.60 (as on 10 November 2020, before the market close at 9:45 AM GMT) based on 29.13x Price/NTM Cash Flow (approx.) on FY20E cash flow per share (approx.). Clients having high risk appetite can keep a close watch on the stock from a long term perspective and take an informed decision as appropriate.
James Fisher and Sons Plc
James Fisher and Sons Plc (LON: FSJ) is an FTSE 250 listed Company, which provides specialised engineering services and marine solutions to the oil & gas, marine and high assurance industries globally.
Investment Highlights - James Fisher and Sons Plc – Sell at GBX 827.32
Key Risks
Trading Update for Q3 FY2020 (30 September 2020) (released on 6 November 2020)
One Year Share Price Chart

(Source: Refinitiv, chart created by Kalkine Group)
Valuation Methodology: Price/Earnings Approach (NTM) (Illustrative)

Conclusion
The Company’s operations were significantly impacted by the outbreak of covid-19, and continue to remain the same, as it does not see any improvement in the trading environment. The revenue for 9 months period was significantly down, while the Company expects full-year underlying operating profit to be in between £35 million-£40 million. FSJ has taken swift actions to reduce costs and improve liquidity position. The Company is seeking an improvement in market conditions to deliver growth to shareholders in future. The stock made a 52-week low and high of GBX 735.00 and GBX 2,190.00, respectively.
Based on the risks associated and support from valuation done using the above method, we have given a “Sell” recommendation for James Fisher and Sons Plc at the current price of GBX 827.32 (as on 10 November 2020, before the market close at 11:40 AM GMT) based on 15.10x Price/NTM Earnings (approx.) on FY20E earnings per share (approx.).
*Dividend Yield may vary as per the stock price movement.
*All forecasted figures and Peer information have been taken from Refinitiv, Thomson Reuters.
Disclaimer
PLEASE BE ADVISED THAT YOUR CONTINUED USE OF THIS SITE OR THE INFORMATION PROVIDED HEREIN SHALL INDICATE YOUR CONSENT AND AGREEMENT TO THESE TERMS.
References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.
This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332.
The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine is not responsible for material posted on this website and does not guarantee the content, accuracy, or use of the content in this site. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated.
Kalkine do not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not in any way endorse or recommend individuals, products or services that may be discussed on this site. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional licensed financial planner and adviser.
Past performance is not a reliable indicator of future performance.